419 studies found for:    Open Studies | "Stomach Neoplasms"
Show Display Options
Rank Status Study
21 Recruiting Early Onset and Familial Gastric Cancer Registry
Condition: Gastric Cancer
Intervention: Behavioral: questionnaires
22 Unknown  Oxaliplatin and S-1 or Oxaliplatin and Capecitabine in Treating Patients With Recurrent, Metastatic, or Unresectable Gastric Cancer
Condition: Gastric Cancer
Interventions: Drug: capecitabine;   Drug: oxaliplatin;   Drug: tegafur-gimeracil-oteracil potassium
23 Not yet recruiting Ultrasonic Scalpel vs. Monopolar Electrocautery for D2 Distal Gastric Carcinoma Surgery
Conditions: Gastric Cancer;   Surgery;   Ultrasonic Scalpel;   Monopolar Electrocautery;   Operation Time;   Blood Loss, Surgical;   Quality of Life;   External Causes of Morbidity and Mortality
Interventions: Device: Monopolar electrocautery;   Device: Ultrasonic scalpel
24 Recruiting Prognosis and Risk Factors of Gastric Cancer in Patients With Intestinal Metaplasia
Condition: Stomach Cancer
Intervention:
25 Not yet recruiting Phase 3 Study of Xelox Followed by Maintenance Capecitabine in the Advanced Gastric Cancer
Condition: Stomach Neoplasms
Intervention: Drug: Capecitabine
26 Unknown  A Study of Oraxol® in Gastric Cancer Patients
Conditions: Advanced Metastatic Gastric Cancer;   Recurrent Gastric Cancer
Intervention: Drug: Paclitaxel
27 Unknown  A Trial of Neoadjuvant TS-1 and Cisplatin for Type 4 and Large Type 3 Gastric Cancer
Condition: Gastric Neoplasm
Interventions: Procedure: Gastrectomy with more than D2 dissection;   Drug: Neoadjuvant chemotherapy(TS-1+CDDP) followed by gastrectomy
28 Recruiting Efficacy of Laparoscopic Subtotal Gastrectomy With D2 Lymph Node Dissection for Locally Advanced Gastric Cancer
Condition: Gastric Cancer
Interventions: Procedure: Laparoscopic gastrectomy;   Procedure: Open gastrectomy
29 Recruiting Multicentric Randomized Study of H. Pylori Eradication and Pepsinogen Testing for Prevention of Gastric Cancer Mortality
Conditions: Helicobacter Pylori Infections;   Atrophic Gastritis;   Gastric Cancer
Intervention: Drug: Triple therapy
30 Recruiting Low-Tox Vs Eox In Patients With Locally Advanced Unresectable Or Metastatic Gastric Cancer
Conditions: Locally Advanced Unresectable Gastric Cancer;   Metastatic Gastric Cancer
Interventions: Drug: Docetaxel;   Drug: Epirubicin;   Drug: Oxaliplatin;   Drug: Capecitabine
31 Unknown  Screening for Gastric Cancer in High-risk Population
Condition: Gastric Cancer
Intervention:
32 Not yet recruiting Serum Cholesterol and Gastric Neoplasm
Condition: Gastric Cancer
Intervention: Other: No intervention
33 Recruiting No Antimicrobial Prophylaxis for Laparoscopic Distal Gastrectomy
Condition: Stomach Neoplasms
Intervention: Procedure: Laparoscopic Distal Gastrectomy
34 Recruiting Study of OTSGC-A24 Vaccine in Advanced Gastric Cancer
Condition: Gastric Cancer
Intervention: Biological: OTSGC-A24
35 Unknown  Qualitative Research for Stage 4 Stomach Cancer and Their Caregivers
Conditions: Stage 4 Stomach/Gastric Cancer;   Patients and Caregivers
Intervention: Behavioral: bulletin board and teleophone depth interview
36 Unknown  Trial of S-1 Plus Cisplatin in Gastric Cancer
Condition: Gastric Cancer
Interventions: Drug: s-1 plus cisplatin;   Drug: 5-Fu plus cisplatin
37 Recruiting Dovitinib Plus Docetaxel in Gastric Cancer
Condition: Gastric Cancer
Intervention: Drug: Dovitinib and docetaxel
38 Recruiting Laparoscopic Versus Open Gastrectomy for Gastric Cancer
Condition: Gastric Cancer
Interventions: Procedure: Open Gastrectomy;   Procedure: Laparoscopic Gastrectomy
39 Recruiting Dovitinib for Gastric Cancer With FGFR2 Amplification
Condition: Gastric Cancer
Intervention: Drug: Dovitinib
40 Recruiting Laparoscopic Staging for Locally Advanced Gastric Cancer in Chinese Patients
Conditions: Gastric Cancer;   Peritoneal Metastases
Intervention: Procedure: Laparoscopic Staging

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years